These data together indicate that interrupting the interaction between FANCD2-V2 and TFG can eventually elevate the tumorigenic potential that over time promotes tumor development, in agreement with the fact that FANCD2-V2 was downregulated in malignant cells [4]. The gene discussed is FANCD2; the disease is neoplasm.